Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia
- 22 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 148, 105120
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severityEmerging Microbes & Infections, 2020
- Torquetenovirus viremia for early prediction of graft rejection after kidney transplantationJournal of Infection, 2019
- Torque teno virus monitoring in transplantation: The quest for standardizationAmerican Journal of Transplantation, 2018
- Development of a standardized real time PCR for Torque teno viruses (TTV) viral load detection and quantification: A new tool for immune monitoringJournal of Clinical Virology, 2018
- Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft RecipientsThe Journal of Infectious Diseases, 2018
- Association between plasma Torque teno virus level and chronic lung allograft dysfunction after lung transplantationThe Journal of Heart and Lung Transplantation, 2017
- Torquetenovirus: the human virome from bench to bedsideClinical Microbiology and Infection, 2016
- TTV DNA plasma load and its association with age, gender, and HCMV IgG serostatus in healthy adultsAGE, 2014